Junli Chang

Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education

Affiliated withKey Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education Shanghai University of Traditional Chinese Medicine Ministry of Education

+3

Research Area

Cancer Research Medicine Biology

Biography

Junli Chang has not added Biography.
If you are Junli Chang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 11	Year
Publication title Cited by 4	2022
Publication title Cited by 4	2021
Publication title Cited by 4	2023
Publication title Cited by 2	2024
Publication title Cited by 2	2024

Other Publications

Article	Year
Molecular mechanisms of Polyphyllin I-induced apoptosis and reversal of the epithelial-mesenchymal transition in human osteosarcoma cells. Journal of ethnopharmacology\| PubMed ID: 25978954	2015
MicroRNAs for osteosarcoma in the mouse: a meta-analysis. Oncotarget\| PubMed ID: 27852052	2016
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo. Scientific reports\| PubMed ID: 28790389	2017
Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis. Oncotarget\| PubMed ID: 29228681	2017
Long non-coding RNAs for osteosarcoma in the mouse: a meta-analysis. Oncotarget\| PubMed ID: 29245999	2017
Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysis. Oncotarget\| PubMed ID: 29568404	2018
Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis. International journal of nanomedicine\| PubMed ID: 29670349	2018
Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transition. Molecular medicine reports\| PubMed ID: 29845238	2018
Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-Analysis. Journal of Cancer\| PubMed ID: 30519318	2018
Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation. International journal of biological sciences\| PubMed ID: 34326690	2021
Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis. Frontiers in genetics\| PubMed ID: 35873470	2022
Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis. Chinese journal of integrative medicine\| PubMed ID: 30484018	2019
Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes. Frontiers in genetics\| PubMed ID: 36824434	2023
A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma. Frontiers in oncology\| PubMed ID: 37377920	2023
(S)-10-Hydroxycamptothecin Inhibits EMT-evoked Osteosarcoma Cell Growth and Metastasis by Activating the HIPPO Signaling Pathway. Combinatorial chemistry & high throughput screening\| PubMed ID: 38369725	2024
Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan\| PubMed ID: 38504531	2024
Cellular Senescence-Related Long Non-coding RNA Signatures Predict Prognosis in Juvenile Osteosarcoma. Phenomics (Cham, Switzerland)\| PubMed ID: 39723224	2024
Notoginsenoside R1 reduces acquired lymphedema and increases lymphangiogenesis by promoting VEGF-C expression via cAMP/PKA/CREB signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology\| PubMed ID: 40020630	2025
Melittin inhibits osteosarcoma growth and by inactivating the Wnt/β-catenin signaling pathway. Journal of Cancer\| PubMed ID: 40969387	2025